DE602005019452D1 - Fettmischungshaltige nahrung - Google Patents

Fettmischungshaltige nahrung

Info

Publication number
DE602005019452D1
DE602005019452D1 DE602005019452T DE602005019452T DE602005019452D1 DE 602005019452 D1 DE602005019452 D1 DE 602005019452D1 DE 602005019452 T DE602005019452 T DE 602005019452T DE 602005019452 T DE602005019452 T DE 602005019452T DE 602005019452 D1 DE602005019452 D1 DE 602005019452D1
Authority
DE
Germany
Prior art keywords
lipid
total weight
acid
dpan
dha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005019452T
Other languages
German (de)
English (en)
Inventor
Bernd Stahl
Guenther Boehm
Christopher Beermann
Johan Garssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005019452(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of DE602005019452D1 publication Critical patent/DE602005019452D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DE602005019452T 2004-11-11 2005-11-11 Fettmischungshaltige nahrung Expired - Lifetime DE602005019452D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04026825A EP1656839A1 (en) 2004-11-11 2004-11-11 Nutrition containing lipid blend
PCT/EP2005/012122 WO2006050975A1 (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Publications (1)

Publication Number Publication Date
DE602005019452D1 true DE602005019452D1 (de) 2010-04-01

Family

ID=34927339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005019452T Expired - Lifetime DE602005019452D1 (de) 2004-11-11 2005-11-11 Fettmischungshaltige nahrung

Country Status (18)

Country Link
US (2) US8053471B2 (enExample)
EP (3) EP1656839A1 (enExample)
JP (1) JP2008519796A (enExample)
CN (2) CN102511818B (enExample)
AT (1) ATE457656T1 (enExample)
AU (1) AU2005303903B2 (enExample)
BR (1) BRPI0517479B1 (enExample)
CA (1) CA2586946C (enExample)
DE (1) DE602005019452D1 (enExample)
DK (1) DK1809125T3 (enExample)
ES (1) ES2341355T3 (enExample)
NZ (1) NZ554629A (enExample)
PL (1) PL1809125T3 (enExample)
PT (1) PT1809125E (enExample)
RU (1) RU2402927C2 (enExample)
SG (1) SG143274A1 (enExample)
UA (1) UA89207C2 (enExample)
WO (1) WO2006050975A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
PT1888081T (pt) 2005-05-23 2017-03-01 Massachusetts Inst Technology Composições contendo pufa e seus métodos de utilização
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
CA2634693A1 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
NZ582329A (en) 2007-06-26 2012-09-28 Nutricia Nv Improving memory in subjects with mini-mental state examination of 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002146A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
CN100542411C (zh) * 2007-09-24 2009-09-23 张国浩 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法
PL2609812T3 (pl) 2007-12-20 2019-02-28 N.V. Nutricia Ciekły produkt zawierający nukleotydy/nukleozydy
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
JP5335601B2 (ja) * 2009-07-30 2013-11-06 ビーンスターク・スノー株式会社 栄養組成物
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
HK1203038A1 (en) 2011-12-27 2015-10-16 Abbott Laboratories Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
EP2861227A4 (en) 2012-06-17 2016-01-27 Matinas Biopharma Inc OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
EP2968246A4 (en) * 2013-03-13 2016-08-03 Matinas Biopharma Inc OMEGA 3 PENTANOIC ACID COMPOSITIONS AND METHODS OF USE
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
FR3045069B1 (fr) 2015-12-14 2019-01-25 Metabolium Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides
BR112018071493A2 (pt) * 2016-04-18 2019-02-19 N.V. Nutricia usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce
WO2019040938A1 (en) * 2017-08-25 2019-02-28 Struct Nutrition, Llc COMPOSITIONS AND METHODS FOR PREVENTING, RELIEVING AND TREATING NEUROLOGICAL INJURY FOLLOWING SKIN TRAUMA
CA3156527A1 (en) * 2019-11-08 2021-05-14 Jose Maria Lopez Pedrosa Bovine milk-isolated powdered exosomes, nutritional compositions and methods
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
KR940003473A (ko) * 1992-08-14 1994-03-12 이순목 n-3 지방산이 축적된 우유 및 우유용 사료조성물
NL9401644A (nl) * 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
AU5346296A (en) * 1995-04-17 1996-11-07 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
US6432468B1 (en) * 1995-05-30 2002-08-13 Suntory Limited Domestic fowl eggs having a high content of highly unsaturated fatty acid, their production process and their use
DE69622722T2 (de) * 1996-11-20 2003-02-27 N.V. Nutricia, Zoetermeer Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
PL343902A1 (en) * 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
CN1660065A (zh) * 1997-03-27 2005-08-31 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
EP0893064B1 (fr) * 1997-07-22 2003-01-15 Societe Des Produits Nestle S.A. Composition lipidique pour formule infantile et procédé de préparation
WO2000020603A1 (en) * 1998-10-05 2000-04-13 Abbott Laboratories Altered fatty acid biosynthesis in insect cells using delta five desaturase
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ITBO20000471A1 (it) 2000-07-31 2002-01-31 Vieri Ridolfi Dispositivo di supporto per prodotti da fumo particolarmente sigarette .
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
EP2255668A3 (en) * 2001-05-14 2012-04-04 Martek Biosciences Corporation Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend

Also Published As

Publication number Publication date
CN102511818A (zh) 2012-06-27
EP2191733A1 (en) 2010-06-02
EP1809125B1 (en) 2010-02-17
CA2586946A1 (en) 2006-05-18
PL1809125T3 (pl) 2010-07-30
EP1809125A1 (en) 2007-07-25
RU2007121665A (ru) 2008-12-20
JP2008519796A (ja) 2008-06-12
NZ554629A (en) 2010-09-30
BRPI0517479B1 (pt) 2015-06-09
US20120027885A1 (en) 2012-02-02
SG143274A1 (en) 2008-06-27
ES2341355T3 (es) 2010-06-18
CA2586946C (en) 2014-09-30
CN101052316B (zh) 2012-02-22
US20080269330A1 (en) 2008-10-30
UA89207C2 (ru) 2010-01-11
BRPI0517479A (pt) 2008-10-07
AU2005303903B2 (en) 2012-05-31
CN102511818B (zh) 2014-12-24
RU2402927C2 (ru) 2010-11-10
ATE457656T1 (de) 2010-03-15
AU2005303903A1 (en) 2006-05-18
US8729123B2 (en) 2014-05-20
CN101052316A (zh) 2007-10-10
EP1656839A1 (en) 2006-05-17
DK1809125T3 (da) 2010-06-07
PT1809125E (pt) 2010-05-20
US8053471B2 (en) 2011-11-08
WO2006050975A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
DE602005019452D1 (de) Fettmischungshaltige nahrung
Nettleton Are n-3 fatty acids essential nutrients for fetal and infant development?
Moriguchi et al. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats
JP2006501840A5 (enExample)
ATE427112T1 (de) Immunstimulierende babynahrung
NO942365L (no) Lipidisk sammensetning for anvendelse som et næringsmiddel eller i næringsmiddelprodukter
DK1121115T4 (da) PUFA-tilskud
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
JP2008519796A5 (enExample)
Briend et al. Lipid intake in children under 3 years of age in France. A position paper by the Committee on Nutrition of the French Society of Paediatrics
Minihane et al. Health benefits of polyunsaturated fatty acids (PUFAs)
EP0437524A1 (en) TRIGLYCERIDES AND NUTRITIONAL COMPOSITION COMPRISING THE SAME.
Gillingham The metabolic fate of alpha linolenic acid (ALA)
Dangat et al. Maternal supplementation of omega 3 fatty acids to micronutrient-imbalanced diet improves lactation in rat
Booyens et al. Margarines and coronary artery disease
Hassam The influence of α-linolenic acid (18: 3ω3) on the metabolism of γ-linolenic acid (18: 3ω6) in the rat
Delplanque et al. Brain docosahexaenoic acid (DHA) levels of young rats are related to alpha-linolenic acid (ALA) levels and fat matrix of the diet: impact of dairy fat
Sheppard Specialty Eggs: n‐3 Fatty Acid‐Enriched Eggs
Taugbol Studies on omega-3 polyunsaturated fatty acids as a supplement to pig nutrition.
Beare-Rogers Challenges for lipid nutritionists
Asif OXIDATION AND POLYMORPHISM OF FATTY ACIDS AND NUTRITIONAL ASPECTS CONJUGATED OF LINOLEIC ACIDS
Park SoYoung et al. Impact of Korean pine nut oil on weight gain and immune responses in high-fat diet-induced obese mice.
González Gallegos et al. Evidence on dietary fats and coronary disease.
Fievez et al. Dietary strategies to modify milk fatty acid composition: potential and limits.
Meers The effect of omega-3 fatty acid supplementation in swine diets on performance parameters, tissue characteristics, and fatty acid composition

Legal Events

Date Code Title Description
8363 Opposition against the patent